Profile resistance of pathogens causing urinary tract infection in the pediatric population, and antibiotic treatment response, at a University Hospital 2010-2011

Vélez Echeverri, Catalina; Serna-Higuita, Lina María; Serrano, Ana Katherina; Ochoa-García, Carolina; Rojas Rosas, Luisa; Bedoya, Ana María; Suárez, Margarita; Hincapié, Catalina; Henao, Adriana; Ortiz, Diana; Vanegas, Juan José; Zuleta, John Jairo; Espinal, David.
Colomb. med ; 45(1): 39-44, Jan.-Mar. 2014. ilus
Artículo en Inglés | LILACS | ID: lil-712449

Documentos relacionados

  1. Caspase-like activity is associated with bacterial infection of the urine in urinary tract diseases.
  2. Predictive phage therapy for <i>Escherichia coli</i> urinary tract infections: Cocktail selection for therapy based on machine learning models.
  3. Coliphage cocktails for controlling antimicrobial-resistant Escherichia coli: emphasizing polyphage and multihost interactions at different levels of multiplicity of infection.
  4. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial.
  5. The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment study.
  6. Distribution and antimicrobial resistance patterns of urinary pathogens in preoperative midstream urine cultures from Chinese patients with urinary calculi: a meta-analysis.
  7. Follow-up blood cultures in E. coli and Klebsiella spp. bacteremia-opportunities for diagnostic and antimicrobial stewardship.
  8. Pharmacodynamics of Temocillin in Neutropenic Murine Infection Models.
  9. Successful use of azithromycin for Escherichia coli-associated renal allograft malakoplakia: a report of two cases.
  10. Efficacy and safety of ceftazidime/avibactam in patients with infections caused by ß-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.